UCB SA (UCBJY)
155.96
-1.81
(-1.15%)
USD |
OTCM |
Nov 18, 16:00
UCB Price : 155.96 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 157.20 | 158.12 | 155.43 | 155.96 | 29026.00 |
| Nov 17, 2026 | 158.13 | 158.60 | 157.53 | 157.77 | 14342.00 |
| Nov 16, 2026 | 163.82 | 164.40 | 161.44 | 161.53 | 20668.00 |
| Nov 13, 2026 | 163.42 | 164.33 | 162.51 | 163.75 | 14056.00 |
| Nov 12, 2026 | 161.62 | 163.75 | 161.62 | 162.40 | 13593.00 |
| Nov 11, 2026 | 161.08 | 162.45 | 160.74 | 162.45 | 12119.00 |
| Nov 10, 2026 | 165.24 | 166.50 | 164.56 | 165.27 | 14563.00 |
| Nov 09, 2026 | 165.39 | 168.64 | 163.95 | 167.76 | 35388.00 |
| Nov 06, 2026 | 158.52 | 162.97 | 158.52 | 161.88 | 21233.00 |
| Nov 05, 2026 | 160.87 | 163.70 | 160.47 | 160.87 | 21713.00 |
| Nov 04, 2026 | 159.58 | 160.10 | 157.61 | 159.68 | 15887.00 |
| Nov 03, 2026 | 155.97 | 156.76 | 153.94 | 153.95 | 15409.00 |
| Nov 02, 2026 | 156.95 | 157.21 | 154.96 | 155.99 | 39856.00 |
| Oct 30, 2026 | 157.64 | 157.84 | 156.08 | 156.80 | 19304.00 |
| Oct 29, 2026 | 155.59 | 156.29 | 154.57 | 155.84 | 17123.00 |
| Oct 28, 2026 | 148.89 | 152.37 | 148.83 | 150.83 | 18261.00 |
| Oct 27, 2026 | 148.69 | 150.50 | 148.69 | 149.57 | 19677.00 |
| Oct 26, 2026 | 148.88 | 151.31 | 148.83 | 150.65 | 28813.00 |
| Oct 23, 2026 | 147.72 | 152.52 | 147.67 | 151.91 | 33988.00 |
| Oct 22, 2026 | 142.71 | 145.64 | 142.59 | 144.70 | 65401.00 |
| Oct 21, 2026 | 120.72 | 121.16 | 119.18 | 119.81 | 62625.00 |
| Oct 20, 2026 | 119.47 | 123.00 | 119.43 | 122.32 | 61610.00 |
| Oct 19, 2026 | 114.52 | 115.12 | 114.20 | 114.20 | 97196.00 |
| Oct 16, 2026 | 114.95 | 115.28 | 114.23 | 114.46 | 70568.00 |
| Oct 15, 2026 | 115.89 | 116.39 | 115.15 | 115.47 | 74772.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1356.96 |
| Novo Nordisk A/S | 38.86 |
| Pfizer Inc. | 27.66 |
| Teva Pharmaceutical Industries Ltd. | 39.07 |
| Astellas Pharma, Inc. | 16.96 |
Price Related Metrics
| PE Ratio | 23.65 |
| PS Ratio | 6.088 |
| PEG Ratio | 0.0264 |
| Price to Free Cash Flow | 43.00 |
| Earnings Yield | 4.23% |
| Market Cap | 59.47B |
| PEGY Ratio | 0.0264 |
| Operating PE Ratio | 19.13 |
| Normalized PE Ratio | 23.45 |